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Abstract
The sphingolipid ceramide elicits several stress responses, however, organisms survive despite increased ceramide but how
they do so is poorly understood. We demonstrate here that the AKT/FOXO pathway regulates survival in increased ceramide
environment by metabolic adaptation involving changes in glycolysis and lipolysis through novel downstream targets. We
show that ceramide kinase mutants accumulate ceramide and this leads to reduction in energy levels due to compromised
oxidative phosphorylation. Mutants show increased activation of Akt and a consequent decrease in FOXO levels. These
changes lead to enhanced glycolysis by upregulating the activity of phosphoglyceromutase, enolase, pyruvate kinase, and
lactate dehydrogenase to provide energy. A second major consequence of AKT/FOXO reprogramming in the mutants is the
increased mobilization of lipid from the gut through novel lipase targets, CG8093 and CG6277 for energy contribution.
Ubiquitous reduction of these targets by knockdown experiments results in semi or total lethality of the mutants,
demonstrating the importance of activating them. The efficiency of these adaptive mechanisms decreases with age and
leads to reduction in adult life span of the mutants. In particular, mutants develop cardiac dysfunction with age, likely
reflecting the high energy requirement of a well-functioning heart. The lipases also regulate physiological triacylglycerol
homeostasis and are important for energy metabolism since midgut specific reduction of them in wild type flies results in
increased sensitivity to starvation and accumulation of triglycerides leading to cardiac defects. The central findings of
increased AKT activation, decreased FOXO level and activation of phosphoglyceromutase and pyruvate kinase are also
observed in mice heterozygous for ceramide transfer protein suggesting a conserved role of this pathway in mammals.
These data reveal novel glycolytic and non-autonomous lipolytic pathways in response to increased ceramide for
sustenance of high energy demanding organ functions like the heart.
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Introduction
Energy balance is regulated by complex homeostatic control of lipid
and glucose metabolism involving signaling pathways in multiple
tissues and organs. Aberrant glucose and lipid metabolism arising from
defects in these pathways accompanies a number of diseases including
cardiovascular disorders, type II diabetes and metabolic syndrome
associated with obesity and insulin resistance. Understanding regula-
tory mechanisms governing glucose and lipid metabolism is funda-
mental for identifying potential therapeutic targets for treatment of
these metabolic diseases. Altered lipid metabolism is one of the
important contributors to obesity and insulin resistance. Dyslipidemia
in obesity is characterized by elevated free fatty acids, triglycerides
(TAG), VLDL and decreased HDL cholesterol. Increased levels of free
fatty acids and lipids such as diacylglycerol and ceramide mediate
insulin resistance by redistribution of fat metabolites to tissues not suited
for lipid storage [1,2].
The sphingolipid, ceramide, is an integral component of cell
membranes and also a bioactive lipid [3]. Ceramide elicits many
cell-stress responses including apoptosis, senescence, inflammation,
mitochondrial dysfunction and recent studies show that it can affect
cellular metabolism. It can impair insulin stimulated glucose uptake,
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it serves as an intermediate linking glucocorticoids and saturated
fatty acids to insulin resistance and has been implicated in the
pathogenesis of lipotoxic cardiomyopathy [4–6]. Strategies that
pharmacologically or genetically decrease ceramide have beneficial
effects in reversing insulin resistance, preventing apoptosis of
pancreatic b-cells and cardiomyocytes [4,7].
Despite the involvement of ceramide in many stress responses,
organisms develop and survive with increased ceramide levels in
certain circumstances. For example, Drosophila mutants of ceramide
kinase and brainwashing (mammalian homolog of alkaline
ceramidase) are viable while mutants of ceramidase are lethal
despite similar increase in ceramide levels [8–11]. Mice and
Arabidopsis deficient in ceramide kinase and mice deficient in
sphingomyelin synthase 1 and 2 are viable despite accumulation of
ceramide [12–16]. A likely explanation is that these organisms
implement adaptive responses that allow them to survive and
maintain equilibrium in the face of stress due to increased ceramide.
These adaptive mechanisms are of critical importance in under-
standing metabolic homeostasis, but have received limited attention
especially in multi-cellular organisms. In this study, we address this
issue using Drosophila loss of function mutation in ceramide kinase
(CERK). Our earlier studies established CERK as an important
regulator of phospholipase C (PLC) signaling and photoreceptor
homeostasis [10]. A mutation in dCERK led to proteolysis of PLC,
consequent loss of PLC activity and failure in light signal
transduction. These defects were due to increased ceramide levels
and not ceramide 1-phosphate (C1P) since levels of C1P did not
change significantly in photoreceptors of dcerk1 mutants.
In recent years, Drosophila has emerged as a useful organism to
study metabolism [17]. The fly has organ systems such as the fat
body (adipose tissue), oenocytes (hepatocyte-like cells), gut
(gastrointestinal tract) and malphigian tubules (kidneys) that
parallel those in mammals. Several studies highlight the conserved
mechanisms of carbohydrate, lipid and energy homeostasis in flies
and genes discovered in Drosophila have provided information
relevant to human physiology including that of the heart [18–27].
We set out to globally discover what genes and metabolites change
in ceramide kinase mutant flies (dcerk1) by gene expression and
metabolic profiling. Integrating information from these analyses with
genetic and biochemical experiments, we show that dcerk1 mutants
survive due to increased activation of AKT and decreased FOXO
level. In the dcerk1 mutants, increase in ceramide leads to decreased
ATP level due to compromised mitochondrial oxidative phosphory-
lation. Metabolic reprogramming to ceramide involves AKT induced
glycolytic utilization of glucose through activation of phosphoglycerate
mutase and also utilization of triglycerides by activation of two intestine
specific lipases, CG8093 and CG6277 in dcerk1. These are novel
downstream targets of AKT/FOXO in glycolysis and lipolysis. With
age, these compensatory mechanisms fail leading to abnormal cardiac
function and decreased life span of the mutants. Gut specific reduction
in these lipases in both wild type and mutant flies results in TAG
accumulation, increased sensitivity to starvation and cardiac dysfunc-
tion. Using mice heterozygous for ceramide transfer protein (CERT) as
a second model of ceramide increase, we substantiate AKT activation,
decrease in FOXO level and activation of glycolytic genes, phospho-
glyceratemutase and pyruvate kinase in amammalian system [28].We
have thus discovered a novel connection in the PI3K-AKT-FOXO
pathway for survival and metabolic adaptation to a ceramide
environment that participates in energy response involving phospho-
glycerate mutase and gut specific lipases, CG8093 and CG6277 as
physiological targets.
Results
dcerk1 mutants exhibit metabolic reprogramming
Ceramide kinase mutants show an increase in steady state
concentration of ceramides without significant decrease in the levels
of ceramide 1-phosphate in whole fly extracts (Figure S1). The increase
in C24:1 ceramide is most dramatic (about 280%) while other
ceramides show between 30–50% increase in the dcerk1 mutants over
control flies. Thus dcerk1 mutants will have to survive in an increased
ceramide environment. An organism’s attempt to adapt to stress or
altered environment involves changes in gene expression and
metabolite levels that aid in reestablishing homeostasis. Therefore,
we reasoned elucidating both transcriptional and metabolite responses
that change in mutants relative to control could help us understand
possible adaptive mechanisms that operate in dcerk1. We carried out a
transcriptome-wide analysis in w1118 and dcerk1 flies. 310 transcripts
were changed significantly in dcerk1 compared to control, with 152
genes being upregulated (.=2.0 fold) and 158 genes being
downregulated (,=0.5 fold, Table S1). To identify pathways and
predicted gene functions corresponding to the altered transcripts, we
employed the DAVID gene ontology (GO) annotation and functional
classification tools [29]. The top GO class for increased genes included
serine type endopeptidases and hydrolases (Figure 1A). Most of the
serine type endopeptidases are mainly expressed in the larval/adult
mid gut (based on FlyAtlas expression patterns) suggesting they are
likely involved in the mobilization of dietary protein. Among the
increased hydrolases were glycosyl hydrolases and those involved in
metabolism of starch, sucrose and galactose and these are also
expressed mainly in the adult gut. Thus, there is a significant
upregulation of midgut genes involved in breakdown of dietary
proteins and sugars in dcerk1. Other classes of upregulated genes in dcerk1
were transporters, oxidoreductases and genes that constitute the
peritrophic envelope, a lining composed of chitin and glycoproteins,
separating the food from the midgut epithelium. The top GO category
for downregulated genes were antimicrobial peptides (AMPs) involved
in the innate immune response. Important metabolic genes that
change in dcerk1 flies are phosphoenolpyruvate carboxykinase (PEPCK,
downregulated) involved in gluconeogenesis, fatty acid synthesis
Author Summary
Ceramide belongs to an important class of lipids called
sphingolipids. An increase in ceramide levels elicits several
stress responses. We have used Drosophila mutated in
ceramide kinase, an enzyme involved in metabolizing
ceramide to understand how an organism adapts to stress
imposed by ceramide. We find that in the mutants,
increased ceramide decreases energy production via
mitochondrial oxidative phosphorylation. The mutants
compensate for decreased energy by upregulating glycol-
ysis, a central pathway of intermediary metabolism.
Another important mechanism that is activated in these
ceramide kinase mutants is lipolysis, which is involved in
breakdown of triglycerides for energy contribution. The
mutants show increased hydrolysis of triglycerides in the
gut, probably to provide sufficient energy for optimal
performance of the heart, a high energy demanding organ.
The upregulation of these pathways in the mutant result
from increased activation of AKT and decreased FOXO. The
modulation of glycolysis and lipolysis by AKT/FOXO is
mediated by novel targets identified in this study. Failure
of these adaptive mechanisms in aging flies lead to
triglyceride accumulation, cardiac abnormalities, and ulti-
mately a decrease in the lifespan of the mutant animals.
The mechanisms identified here could have clinical
implications in diseases associated with ceramide such as
diabetes and obesity.
AKT/FOXO Mediated Metabolic Adaptation to Ceramide
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(downregulated), carnitine palmitoyltransferase (b-oxidation, upregu-
lated) and pyruvate kinase (upregulated) involved in glycolysis.
Since gene expression changes in known targets of FOXO such
as PEPCK and AMPs were observed, we analyzed if other
differentially expressed genes in our microarray dataset could be
potential targets of FOXO. Recent ChIP-chip analysis revealed
about 700 direct FOXO targets in adult Drosophila [30]. Using this
information coupled with ChIP peak Annopackage we identified
that 40 genes from our microarray data contained FOXO binding
sites and could be potential targets of FOXO (Table S2) [31].
Metabolomic analysis of dcerk1 mutants reveals changes
in glycolysis and TCA cycle
In order to understand how changes in gene expression
influence metabolism, we compared the metabolic profiles of
w1118 and dcerk1 by mass spectrometry. About 175 metabolites
were identified and classified into different functional pathways
(Table S3). The fold changes (dcerk1/w1118) for various amino
acids, fatty acids, sugars and intermediates in glycolysis, TCA
cycle, are shown in Figure 1B. Two important metabolic pathways
that were different between w1118 and mutants were glycolysis and
TCA cycle. dcerk1 exhibited increase in lactate and decrease in
pyruvate, both glycolytic intermediates. While oxaloacetate and a-
ketoglutarate were decreased, other TCA cycle intermediates,
citrate, malate, fumarate and succinate were increased. The
altered steady state concentrations of the metabolites indicate
change in the flux of these pathways. Glycolysis, TCA cycle and
mitochondrial oxidative phophorylation share control of energy
metabolism and they interact to match cellular ATP demand with
ATP production.
To assess mitochondrial oxidative phosphorylation, we
measured the enzyme activities of the five complexes of the
electron transport chain in mitochondrial-enriched fractions
Figure 1. Metabolic reprogramming in dcerk1 mutants. A. Functional classification of genes whose expression is altered in dcerk1 mutants
compared to control w1118 flies. RNA extracted from control and mutant flies was hybridized to Affymetrix Drosophila 2.0 microarrays and
experiments were carried out in triplicate. Gene expression analysis revealed 152 genes were increased (2-fold or more) and 158 genes were
decreased (0.5 fold or less) in dcerk1 compared to w1118. DAVID gene functional annotation tool and functional classification tool were used to
annotate and classify the increased and decreased genes into functionally related gene groups. The top GO terms obtained for increased and
decreased genes are listed along with the number of genes altered in each category and the statistical significance based on modified Fisher Exact P-
Value. Serine type endopeptidases and hydrolases are upregulated while immune response genes are downregulated in the mutant. B. Metabolomic
profiling reveals changes in glycolysis and TCA cycle metabolites in dcerk1 compared to w1118. Control and mutant fly extracts were subjected in
triplicate to GC/MS, LC/MS and LC/MS/MS platforms to compare relative levels of several metabolites. The fold change, dcerk1/w1118 is shown for each
metabolite. A p value of ,0.05 and a q value of ,0.1 (false discovery rate) is considered highly statistically significant (marked by a red *). Among
glycolysis intermediates, pyruvate and lactate meet these stringent criteria; pyruvate level is decreased while lactate level is increased in the mutant.
Among TCA cycle metabolites, oxaloacetate and a-ketoglutarate are decreased while citrate and malate are increased. Fumarate and succinate are
also increased and meet the less stringent statistical criteria of approaching significance (p 0.05 20.1 and q 0.1 or less, marked by a blue *). Most
amino acids (other than cysteine and methionine) and sugars do not show significant differences. Among fatty acids, Dodecanedioate, a long chain
fatty acid is decreased significantly in the mutant. This could be due to its degradation to acetyl CoA and succinate, the latter being important for
gluconeogenesis during starvation.
doi:10.1371/journal.pgen.1003556.g001
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from control and mutant flies. As seen in Figure 2A, the
activities of complexes II, III, IV and V are decreased while I is
increased in the mutant compared to control. To test if
compromised oxidative phosphorylation led to alteration in
energy level, we measured ATP level in mitochondria isolated
from w1118 and mutant flies. Indeed, dcerk1 showed a 40%
decrease in ATP level relative to w1118 (Figure 2B). Since
metabolic profiling emphasized changes in glycolysis, we first
examined if there are changes in gene expression of enzymes of
the glycolytic pathway in addition to pyruvate kinase, which was
shown to be upregulated by microarray analysis. Quantitative
PCR analysis of the different glycolytic genes showed a 15-fold
increase in phosphoglycerate mutase (Pglym), 3–4 fold increase
in both enolase (Eno) and pyruvate kinase (Pyk) expression,
enzymes that catalyze later reactions in the glycolytic pathway
(Figure 2C). Interestingly, traditional regulators of glycolysis
such as hexokinase and phosphofructokinase are either un-
changed or decreased. To test if increase in transcript levels
translated to increased activity, we measured activity of the
various enzymes. Pglym, Pyk, Eno and Lactate dehydrogenase
(Ldh) showed increase in enzyme activity (Figure 2D). Meta-
bolically these changes in transcript and enzyme activity result
in a 1.7 fold increase in lactate in dcerk1 (Figure 1B). Thus a
significant portion of glucose metabolized by the glycolytic
pathway was converted to lactate by the action of lactate
dehydrogenase. The above results suggest that the increased
reliance on glycolysis by dcerk1 compensates for their decreased
ability to produce ATP through oxidative phosphorylation.
Increased activation of AKT is required for survival of
dcerk1 mutant flies
Since dcerk1 mutants show specific changes in glycolysis and
differentially expressed genes in our transcriptional profiling data
contained FOXO binding sites, we decided to test if AKT, a
central modulator of metabolism and upstream regulator of
FOXO was altered in dcerk1. AKT is a master regulator of survival,
proliferation and cellular metabolism [32,33]. AKT activation
requires TOR dependent phosphorylation of Ser-473 (Ser-505 in
Drosophila) at the C-terminus [34,35]. We measured AKT
activation in dcerk1 flies by measuring the level of Ser-505
phosphorylated AKT protein by Western analysis. Phosphorylated
AKT (seen as two major and one minor band) was increased while
total AKT level was not different from w1118 (Figure 3A). The blot
also shows reduced levels of total and phospho AKT in akt4226, a
hypomorphic allele of AKT used in this study [36]. Densitometric
scanning of Western blots shows about 50% increase in pAKT
level in the dcerk1 mutant (Figure 3B). To test if activity of the
upstream activator PI3K is increased, we used an in vivo reporter,
which contains the PH domain of general receptor for phospho-
inositide fused to GFP (tGPH) [37]. tGPH is increased in the cell
membrane when PI3K activation increases PIP3 level. We
observed an increased membrane association of tGPH in dcerk1
compared to control in the adult mid gut (Figure 3C, top panel)
and larval fat body (Figure 3C, bottom panel). These results
suggest increased PI3K activation leads to increased AKT
activation in dcerk1. A likely reason for the increased activation of
PI3K could be the increased availability of PIP2 in the dcerk
1
mutant [10].
AKT mediates many of the alterations in metabolism through
regulation of FOXO and in Drosophila there is a single homolog of
the FOXO transcription factor family [38–41]. To test the status
of FOXO, we measured FOXO transcript level in mutant flies
and found that it was significantly decreased (Figure 3D). AKT
activation in mammalian cells has been shown to lead to low
FOXO level due to ubiquitination and proteosomal degradation
of FOXO [42]. To address this possibility in Drosophila, we reduced
ubiquitin mediated proteosomal degradation in dcerk1 using a
dominant temperature sensitive (DTS) mutation, DTS5 that
affects the b6 proteosomal subunit [43]. Since ubiquitous
expression of DTS5 resulted in lethality, we overexpressed
DTS5 in photoreceptors using the GMR GAL4 driver and
measured FOXO transcript level in heads. If FOXO is targeted
for degradation in dcerk1, then expressing DTS5 should result in
restoration of FOXO level and this is indeed the case (Figure 3D).
Thus increased activation of AKT leads to downregulation of
FOXO transcription factor in dcerk1 mutant flies.
To evaluate the importance of increased AKT activity in dcerk1
homozygous mutants, we generated akt4226, dcerk1 double homo-
zygotes. While dcerk1 or akt4226 homozygous flies alone are viable,
double mutants are early larval lethal. Hence, compromised AKT
function was incompatible with survival of dcerk1 flies.
Metabolic reprogramming in dcerk1 involves increased
glycolytic flux through activation of phosphoglycerate
mutase and downstream glycolytic enzymes
To test if AKT may be required for the increased glycolytic flux
in mutants, we generated dcerk1 flies with reduced AKT function
wherein one wild type copy of AKT was replaced with the
hypomorphic allele of AKT. dcerk1 flies heterozygous for akt 4226
(referred to as dcerk1.akt/dcerk1) survive to adulthood and we have
used them in subsequent experiments for evaluating the effects of
reducing AKT function in dcerk1. The data from our studies with
Pglym are shown here since it showed significant increase in both
transcript and enzyme activity in mutant flies (Figures 3E, 3F).
dcerk1.akt/dcerk1 flies showed reduction in Pglym transcript and
enzymatic activity. akt4226/+ flies were also tested in the above
experiments and they did not differ significantly from w1118 control
suggesting that heterozygous state of AKT alone was not
responsible for the changes (Figures 3E, 3F). Densitometric
scanning of Western blots reflects a 50% decrease in total AKT
and 30% decrease in pAKT levels in the akt4226/+ (Figures S2A,
S2B). As mentioned earlier, AKT alters metabolic balance through
downregulation of FOXO. We tested its involvement in regulating
Pglym, by overexpressing FOXOTM, a constitutively active form
of the protein that localizes to the nucleus [44]. We expressed
FOXOTM using a muscle driver, myosin heavy chain (MHC)-
GAL4 and analyzed whole body Pglym transcript level [45].
Indeed, FOXOTM overexpression in the muscles resulted in
significant decrease in Pglym transcript (Figure 3G), suggesting
Pglym regulation is FOXO dependent.
The measurement of steady state levels of glucose (mammals)
and trehalose (Drosophila) is an indicator of glycolytic utilization of
sugars for energy metabolism. Therefore, we tested if AKT is
required for maintaining normal trehalose levels in dcerk1 mutants.
Trehalose levels in fly extract of dcerk1 were 90% of the control
flies, whereas a reduction of akt dosage in dcerk1 mutants resulted in
an increase in trehalose (Figure 3H). Circulating trehalose levels
also followed a similar trend as the whole body trehalose
measurements in these flies (data not shown). We then globally
reduced Pglym expression by ubiquitous RNAi mediated knock-
down using the actin-Gal4 driver (Figure S3). Notably, this
reduction resulted in semi lethality with 40% of the expected
number of flies reaching adulthood in dcerk1. Trehalose levels
increased by about 20% in w1118 and by 50% in dcerk1 when Pglym
levels were reduced (Figure 3I). Hence, our results suggest
increased glycolytic flux through Pglym is not only important for
survival but also for maintaining near physiological levels of
trehalose in dcerk1 mutants.
AKT/FOXO Mediated Metabolic Adaptation to Ceramide
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Figure 2. dcerk1 mutants show decreased mitochondrial oxidative phosphorylation, lower ATP level, and increased glycolysis
compared to control flies. (A). The activity of each of the electron transport chain complexes is measured spectrophotometrically using specific
substrates and inhibitors in mitochondria isolated from control and mutant flies. Specific activity per mg of mitochondrial protein was calculated and
then normalized to w1118. Mitochondria were prepared from 1000 flies and 3 replicates were carried out. Error bars represent standard deviation. (B).
ATP level is measured in w1118 and mutant fly mitochondria by a bioluminescence assay using luciferase catalyzed oxidation of luceferin which is ATP
dependent. The amount of ATP is calculated per mg of mitochondrial protein and normalized to w1118. The relative level of ATP in the mutant
mitochondria is 60% of w1118. n = 3, error bars represent standard deviation. (C). QPCR analysis of transcripts encoding glycolytic enzymes show a 16–
18 fold increase in Pglym, 3–4 fold increase in Eno and 4–5 fold increase in Pyk levels in dcerk1 relative to w1118. n = 3, error bars represent standard
deviation. (D). Measurement of specific activities of glycolytic enzymes show increase in Pglym, Eno, Pyk and Ldh activities of dcerk1 compared to
w1118 while that of hexokinase is not significantly different. Specific activity of each enzyme is determined per mg of protein and then normalized to
w1118. n = 3, error bars represent standard deviation.
doi:10.1371/journal.pgen.1003556.g002
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Metabolic adaptation in dcerk1 involves increased
mobilization of TAG through novel lipases, CG8093 and
CG6277
Our experiments thus far suggest that dcerk1 flies attempt to
adapt to reduced energy availability. Triacylglycerol (TAG) is one
of the major energy reserves, which is stored as cytoplasmic lipid
droplets primarily in the adipose tissue [46]. In Drosophila, in
addition to fat body cells, other tissues, most notably, the gut,
oocytes, larval imaginal discs and oenocytes also accumulate TAG
as intracellular lipid droplets [47]. During times of energy need
such as starvation, stored TAG is hydrolyzed from these depots by
activation of lipolytic mechanisms [48]. Fatty acids generated via
lipolysis by lipases can be used for energy production through b-
oxidation. Stored lipids are transported through the hemolymph as
lipoprotein particles called lipophorins. So, we decided to test if
energy rich TAG stores are altered in dcerk1 and if so, does the
AKT/FOXO pathway play a role in this process.
We measured whole animal TAG levels in ad libitum fed and
20 h starved w1118 and dcerk1 flies. The mutant flies showed 20%
less TAG than w1118 in the fed state and 50% less TAG in the
starved state (Figure 4A). The decrease in TAG in the starved state
is accompanied by increased free fatty acid and glycerol in whole
fly extracts (Figures 4B, 4C). Since TAG levels were significantly
altered in the starved state, we assessed the ability of dcerk1 to
survive starvation stress. As shown in Figure 4D, the susceptibility
of mutant flies to starvation was similar to w1118. These results
suggest that dcerk1 mutant likely rely on increased TAG hydrolysis
to survive starvation stress. To test if AKT mediated compensation
Figure 3. Increased glycolytic flux in dcerk1 compared to w1118 due to activation of Pglym and downstream glycolytic enzymes
through AKT. (A). Total AKT and phospho AKT are monitored in control and mutant flies by Western blots. One band is observed for total AKT and it
is not significantly different between w1118 and mutant. Two major bands and one minor band are observed for phospho AKT and these are increased
in dcerk1 compared to w1118. The blots also show that total AKT and phospho AKT are both reduced significantly in the hypomorphic allele akt4226
used in this study. (B). Quantification of total AKT and phospho AKT levels. Densitometric scanning of total AKT and phospho AKT bands from
Western blots was carried out. The phospho AKT graph represents the average obtained after combining the values from all three bands observed on
blots. The values were normalized to w1118 taken as 100%. (C). tGPH staining is monitored in control (upper left panel) and dcerk1 (upper right panel)
adult midgut. The lower left panel shows tGPH staining in control while the lower right panel shows that in mutant larval fat body. There is increased
tGPH staining at the cell membranes (compare arrows) indicating increased PIP3 levels and therefore increased PI3K activity. In addition to plasma
membrane, nuclear tGPH is also increased in dcerk1 gut since it has been reported that nuclear tGPH is also visible in many cell types when PIP3 levels
are increased in cells. Midguts from 15–20 flies were visualized in each experiment and three independent experiments were carried out. For
visualizing tGPH in fat body, 15–20 early third instar larvae were used in each experiment and three independent experiments were carried out. Scale
bar represents 50 mm. (D). FOXO transcript level is measured by QPCR and shows a 60% reduction in in dcerk1 flies compared to w1118. FOXO
transcript level increases in the mutant heads when proteosomal degradation is inhibited by overexpressing DTS5 subunit in dcerk1 photoreceptors
compared to w1118 or DTS5 without driver in dcerk1 head samples. (E, F). Transcript level (E) and enzyme activity (F) of Pglym are significantly
decreased when AKT activity is genetically reduced in dcerk1 suggesting AKT mediates Pglym activation in dcerk1. (G). Overexpression of constitutively
active FOXO in the muscles (MHC-GAL4) significantly decreases whole body Pglym transcript level. n = 3, error bars represent standard deviation. (H).
Reduction of AKT in dcerk1 increases total body trehalose level. Trehalose level is calculated per mg of protein and normalized to w1118 level. n = 3,
error bars represent standard deviation. (I). While actin GAL4 driver or UASPglymRNAi transgene individually have no effect on trehalose level,
combining them increases whole animal trehalose by 20% in w1118 and 50% in dcerk1. n = 3, error bars represent standard deviation.
doi:10.1371/journal.pgen.1003556.g003
AKT/FOXO Mediated Metabolic Adaptation to Ceramide
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Figure 4. CG8093 and CG6277 are novel lipases in the gut activated by AKT/FOXO in dcerk1. (A). Relative TAG level in ad libitum fed
dcerk1 is 80% of w1118 and increases to 120% when AKT is reduced. Relative TAG level in 20 hr starved dcerk1 is 50% of w1118 and significantly
increases when AKT is reduced. n = 3, error bars represent standard deviation. (B). Free fatty acids were measured in lysates prepared from starved
w1118 and dcerk1 flies. Mutants show increased free fatty acids compared to w1118. (C). Glycerol was measured in lysates prepared from starved w1118
and dcerk1 flies. Mutant shows increased glycerol compared to w1118. (D). w1118, dcerk1, akt/+ and dcerk1.akt/dcerk1 flies are subjected to starvation and
the number of surviving flies is recorded at 6 hr intervals. 200 flies divided into 10 groups for each genotype are used in one experiment. Three
independent experiments are performed and the average percentage survival relative to w1118 is shown for each time interval. Reduction in AKT
increases the starvation sensitivity of dcerk1 flies. (E). QPCR analysis shows transcript levels of two lipases CG8093 and CG6277 (identified by
microarray analysis) are increased in dcerk1 relative to w1118 both in the fed and 20 h starved state. Both transcript levels are decreased upon
reduction of AKT in dcerk1. n = 3, error bars represent standard deviation. (F). Overexpression of constitutively active FOXO in the midgut decreases
whole animal transcript levels of CG8093 and CG6277 while fat body specific expression does not significantly affect them in dcerk1. FOXO
overexpression with each driver is quantified by QPCR using FOXO primers and normalized. n = 3, error bars represent standard deviation. (G). Midgut
specific overexpression of constitutively active FOXO increases whole animal TAG level in dcerk1. The TAG level in dcerk1 expressing esg-GAL4 driver is
taken as 100%. (H). Constitutive FOXO represses CG8093 in luciferase reporter assays. A 2.4 kb fragment (genomic region between 1773 bp to
4177 bp from transcription start site) containing FOXO core motifs upstream of CG8093 in a luciferase reporter vector or a 1.3 kb fragment (region
between 2842 bp and 4177 bp) deficient of the FOXO motifs was cotransfected with constitutive dFOXO A3. FOXO represses transcription of the
2.4 kb fragment while the repression is less when the binding sites are deleted. (I). Dissected adult midguts stained with Oil Red O show significantly
reduced lipid staining in starved dcerk1 compared to w1118. dcerk1 mutants with reduced AKT show comparatively more Oil Red O staining in the
midgut. 15–20 guts are examined for each genotype in one experiment, which is carried out three times. Scale bar represents 50 mm. Magnified view
of dissected adult midguts from w1118 and dcerk1.akt/dcerk1 show many Oil Red O stained puncta while they are significantly reduced in dcerk1. Scale
bar represents 50 mm.
doi:10.1371/journal.pgen.1003556.g004
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allowed dcerk1 to survive starvation, we subjected dcerk1.akt/dcerk1
flies to starvation stress. These flies died at a faster rate than dcerk1
showing reduction of AKT function in dcerk1 led to starvation
sensitivity (Figure 4D). TAG level in these flies was significantly
higher than in dcerk1, both in the fed and starved states (Figure 4A).
The starvation sensitivity of these flies despite increased TAG level
suggested that they were unable to properly hydrolyze their TAG
stores via lipolysis when AKT activity is reduced. Thus AKT
dependent lipases may provide a critical function in dcerk1 flies.
In order to identify lipases that are activated in dcerk1, we first
tested transcript levels of known fat body lipases in Drosophila,
which include Brummer (ATGL homolog), CG11055 (putative
homolog of hormone sensitive lipase) and CG8552 (homolog of
major triglyceride lipase in a related insect) [19,48]. The transcript
level of Brummer was decreased in dcerk1 (0.5 fold compared to
control) while that of the other two lipases did not show changes
(data not shown). Thus traditional lipases were not upregulated for
increased TAG utilization in dcerk1. We then pursued potential
candidates from microarray studies. Our microarray analysis
identified that amongst the 60 lipases that have been identified in
Drosophila, expression levels of two genes, CG8093 and CG6277,
that encode predicted TAG lipases were increased in dcerk1.
CG8093 is an acid lipase of the a/b hydrolase family related to
human lysosomal acid lipase while CG6277 is a neutral lipase
showing homology to lipoprotein lipase and to pancreatic
triacylglycerol lipase family. Both CG8093 and CG6277 contain
the catalytic triad of Ser, His, Asp residues important for lipase
activity. Earlier studies involving microarray analysis in Drosophila
demonstrated that these lipases are repressed by high sugar and in
situ hybridization studies showed they were expressed in the
midgut [49]. Our QPCR results also showed that these genes were
highly expressed in the midgut (Figure S4). To test if these lipases
could facilitate TAG utilization in dcerk1, we first examined their
transcript levels in fed and starved states (Figure 4E). Both genes
were upregulated in dcerk1. This is an AKT mediated adaptive
response since the transcript levels were downregulated when
AKT is reduced in dcerk1. To evaluate the involvement of FOXO,
we overexpressed FOXOTM using gut (esg-GAL4) and fat body
(C564-GAL4) specific GAL4 drivers [50,51]. Gut specific overex-
pression of FOXOTM decreased whole animal lipase transcripts
while fat body GAL4 did not alter expression significantly in dcerk1
(Figure 4F). Overexpression of FOXOTM in the gut also resulted
in higher TAG level in dcerk1 compared to control (Figure 4G).
The expression of these lipases could be regulated directly or
indirectly by FOXO. Our earlier analysis identified FOXO
binding sites upstream of CG8093 (Table S2) and thus could be a
potential target of FOXO. To test if negative regulation of
CG8093 by FOXO is mediated through these sites, we performed
luciferase reporter assays. A 2.4 kb fragment containing two
FOXO motifs from the regulatory region of CG8093
(pGL4CG8093 2.4 kb) and a fragment in which the motifs were
deleted (pGL4CG8093 1.3kbdel) were cloned in a reporter vector
containing the luciferase gene (pGL4). Drosophila S2 cells were
cotransfected with constitutively active FOXO along with each of
these constructs and luciferase activity was measured after 30 h
[40]. Constitutively active FOXO suppresses the luciferase activity
of pGL4CG8093 2.4 kb and this is considerably relieved in
pGL4CG8093 1.3kbdel, which is deficient of the FOXO binding
sites (Figure 4H). This suggests FOXO could act via these sites to
regulate CG8093 transcription. Our search for FOXO binding
sites was limited to 10 kb upstream of the microarray target genes
and CG6277 was not identified in this analysis. The promoter
region of CG6277 does not contain obvious FOXO binding sites
suggesting transcriptional regulation either takes place through the
interaction with other transcription factors or is indirectly
mediated through FOXO dependent induction of a transcriptional
repressor protein. A possible candidate could be sugarbabe, which
encodes a zinc finger protein. An earlier study that analyzed sugar
dependent gene expression profiles in Drosophila larvae identified
CG6277 could be negatively regulated by sugarbabe [49]. Our
analysis of sugarbabe transcript in dcerk1 mutants suggests its level
is low, which would be consistent with the observed upregulation
of CG6277 transcript level. Also, analysis of FOXO binding sites
identifies two potential regions within 10 kb upstream of
sugarbabe (data not shown). Thus a possible mode of regulation
could be FOXO activates sugarbabe, which in turn negatively
regulates CG6277. Thus downregulation of FOXO in dcerk1 could
lead to activation of CG6277. These results suggest that increase in
CG8093 and CG6277 through AKT/FOXO could lead to
increased lipolysis and decreased TAG level in dcerk1.
To examine whether increased hydrolysis of fat from the gut did
occur as a result of increased lipase activity, guts isolated from
w1118, dcerk1 and dcerk1.akt/dcerk1 were stained with the neutral lipid
dye Oil Red O under starved conditions (Figure 4I). Oil Red O
staining was evident in w1118 gut while dcerk1 showed little staining.
Midgut isolated from dcerk1.akt/dcerk1 also stained well with Oil
Red O (Figure 4I). Oil Red O puncta representing lipid droplets
were clearly visible in w1118 and dcerk1 with reduced AKT but were
substantially decreased in dcerk1 midgut (Figure 4I, bottom panel).
To ensure that changes in gene expression and increased
utilization of lipid in the gut are not to due to compromised gut
integrity or defective epithelial renewal, we tested if dcerk1 gut were
morphologically different from w1118 gut. We observed that gut
length, width and ability to ingest food were not different between
control and mutant flies (data not shown). Epithelial integrity and
epithelial renewal were also assessed as described in Figure S5 and
these data suggest that gut integrity or epithelial renewal in the gut
is largely uncompromised in dcerk1.
Midgut specific knock down of CG8093 and CG6277
results in TAG accumulation, starvation sensitivity and
cardiac defects
Our data suggest that increased expression of CG8093 and
CG6277 leads to increased lipolysis and a concomitant decrease in
TAG level in dcerk1. To ascertain this observation, we asked if
impairing the function of these lipases in dcerk1 would lead to
accumulation of TAG in the mutant. We attempted to reduce
their levels by ubiquitous expression of UAS-CG8093 RNAi and
UAS-CG6277 RNAi constructs in dcerk1. However these condi-
tions resulted in lethality of both wild type and dcerk1 flies. Since
these lipases are expressed predominantly in the gut, we next
drove the RNAi constructs using the midgut specific driver esg-
GAL4 and were able to obtain adult flies. RNAi resulted in 80%
reduction in the transcript levels of the lipases in control and dcerk1
(Figure S6). Midgut specific knockdown of each of these lipases
resulted in significant increase in whole animal TAG levels in
dcerk1 (Figures 5A, 5B). Reduction of these lipases also resulted in
increased TAG in control flies (Figures 5A, 5B). Gut specific
reduction of the lipases also resulted in increased sensitivity to
starvation in both wild type and mutant background compared to
GAL4 driver and RNAi control flies (Figures 5C, 5D). Staining of
guts isolated from knockdown flies with Oil Red O showed
increase in the number of Oil Red O puncta indicative of defective
mobilization of lipid stores (Figure S7). These results collectively
suggest that both lipases are important for utilization of TAG and
maintenance of TAG homeostasis not only in the mutant but also
in wild type flies. Additionally, the life span of wild type and dcerk1
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flies is significantly reduced upon gut specific knockdown of
CG6277 (data not shown).
Heart function in dcerk1 mutants with lipase or Pglym
knockdown
The heart has a high demand for energy and relies on fatty acids
derived from lipolysis of lipoprotein bound TAG by lipases as
energy substrates [52]. Cardiac dysfunction is linked to altered
energy metabolism in many instances [53]. To test if the two
lipases played a role in this process, we tested if their reduction in
wild type flies compromised cardiac function using a variety of
heart performance assays that have been developed in Drosophila
[21]. Heart function was compromised in one-week old gut
specific knockdown of CG6277 as manifested by decreased heart
Figure 5. Knockdown of CG8093 and CG6277 in the midgut increases whole body TAG, starvation sensitivity in w1118 and dcerk1
flies and knockdown of CG6277 also leads to cardiac defects. (A). Midgut specific reduction in CG8093 increases whole body TAG level to
325–350% in control w1118 flies and about 275% in dcerk1 mutants. The TAG level of driver is taken as 100%. n= 3, error bars represent standard
deviation. (B). Midgut specific reduction in CG6277 increases whole animal TAG to 150% in control w1118 flies and about 275%–300% in dcerk1
mutants. The TAG level of driver is taken as 100%. n = 3, error bars represent standard deviation. (C). Reduction in CG8093 lipase increases the
starvation sensitivity of wild type and dcerk1 flies. CG8093 RNAi flies, esgGAL4 driver flies, 8093 RNAi combined to esgGAL4 in wild type and dcerk1 are
subjected to starvation and the number of surviving flies is recorded at 6 hr intervals. 200 flies divided into 10 groups for each genotype are used in
one experiment. Three independent experiments are performed and the average percentage survival is shown for each time interval. (D). Reduction
in CG6277 lipase increases the starvation sensitivity of wild type and dcerk1 flies. CG6277 RNAi flies, esgGAL4 driver flies, 6277 RNAi combined to
esgGAL4 in wild type and dcerk1 are subjected to starvation and the number of surviving flies is recorded at 6 hr intervals. (E). Quantification of
cardiac function parameters in RNAi knockdown of CG6277 in wild type and dcerk1. Knockdown results in decreased heart rate in wild type flies and a
similar trend in dcerk1, increased heart period in both backgrounds, longer diastolic interval in control and mutant and no significant change in
systolic interval. n = 11–13 for each group. Bar represents standard error of mean and statistical significance was determined using Student’s t test;
* denotes P,= 0.05-0.01, ** is P,=0.01-0.001 is and *** denotes P,= 0.001-0.0001.
doi:10.1371/journal.pgen.1003556.g005
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rate or increased heart period primarily due to an increased
diastolic interval (Figure 5E). Knockdown of CG6277 in dcerk1
mutant flies also resulted in increased heart period and a trend
towards decreased heart rate (Figure 5E). One-week old dcerk1
alone did not show significant changes in heart parameters, and
only a slight trend towards a slower heart rate and dilation
(increased systolic and diastolic diameters). While gut specific
knockdown of CG8093 in wild type and in dcerk1 flies did not show
significant changes in most of the parameters tested for heart
function, heart period is affected in dcerk1 due to expansion of
diastolic interval, pointing to the importance of this lipase for heart
function in dcerk1 flies (Figure S8).
Since the knockdown of lipases resulted in increased sensitivity
to starvation and cardiac defects, we also tested the effects of
downregulating the glycolytic gene, Pglym in sensitivity to
starvation and cardiac functions in wild type and mutant
backgrounds. Ubiquitious knockdown of Pglym results in a
significant increase in sensitivity to starvation stress in wild type
and dcerk1 (Figure S9). Evaluation of various heart function
parameters with Pglym knockdown flies in both wild type and
dcerk1 mutant backgrounds showed a decrease in diastolic and
systolic diameters resulting in a somewhat constricted phenotype
without significant changes in other parameters (Figure S9). This is
reminiscent of cardiac constricted phenotype of eas mutants, which
show aberrations in phosphatidylethanolamine synthesis and
elevated SREBP activity [26].
Failure of adaptive mechanisms in dcerk1 mutants leads
to cardiac defects and decreased life span
To test if the adaptive mechanisms we observe in young dcerk1
flies (less than one week) is sustained or fails with age, we tested for
AKT activation and measured FOXO transcript level in aged
dcerk1 (6 weeks). We observe a decrease in AKT activation and 4-
fold increase in FOXO transcript level in older flies (data not
shown). Consequently, Pglym activity decreases significantly in old
dcerk1 flies (Figure 6A) leading to increased trehalose level (data not
shown). Similarly, transcript levels of both lipases decrease with
age (Figure 6B), leading to 50% increase in TAG level in old dcerk1
(data not shown). These results suggest the efficiency of the
compensatory mechanisms decrease with age in the mutant flies.
The decompensation leads to deterioration in many indices of
heart performance between young and three-week old dcerk1 flies
(Figure 6C), a time point at which we begin to observe noticeable
decrease in transcript levels of the lipases in the mutant. These
changes follow a similar trend as those observed when CG6277
lipase is knocked down in healthy three-week old wild type flies
(Figure 6D). In both these situations in addition to heart rate and
heart period changes, we also observe dilated heart chamber,
perhaps due to increased dependence of heart function on this
lipase with aging. We chose an interim period of three weeks
because CG6277 lipase knockdown flies do not survive for six
weeks. Thus, a decrease in CG6277 compromises cardiac function
likely due to altered energy balance resulting from decreased TAG
hydrolysis as observed in wild type flies when the transcript levels
are reduced by RNAi or in aging dcerk1 mutants when AKT
mediated compensatory changes begin to fail. We then tested
whether impaired mitochondrial function and age related
pathology such as triglyceride accumulation and decline in cardiac
function impacted the life span of dcerk1. While 90% of the mutants
die by day 60, only 20% of the controls are dead by this time,
suggesting the adult life span of the mutant flies is shortened
(Figure 6E).
We finally asked whether the adaptive mechanisms to increased
ceramide identified here using Drosophila dcerk mutants are likely
important in other scenarios where ceramide is increased. One
example is the mouse ceramide transfer protein mutant, which
accumulates ceramide and dies around embryonic day 11.5 [28].
These embryos show severe mitochondrial degeneration, de-
creased phospho AKT level and cardiac defects suggesting a likely
failure of the adaptive mechanism. CERT heterozygous mice are
viable, show mitochondrial damage and stress but not as severe as
the homozygotes. We tested if our central results of AKT
activation and decrease in FOXO level are observed in CERT
heterozygous mice. Indeed, we see increased phosphoAKT level
and decreased levels of different FOXO transcripts (Figures 7A,
7B). While results from liver extracts are shown here, down
regulation of FOXO is also observed in other tissues such as
intestine and skeletal muscle. We also observe an increase in
transcripts of phosphoglycerate mutase and pyruvate kinase,
suggesting a likely increase in glycolysis in these animals
(Figure 7C). We then tested some of the mammalian lipase family
members that showed homology to CG8093 (LIPA, LIPF, LIPM)
and CG6277 (pancreatic lipoprotein 1, pancreatic lipoprotein
related protein, lipoprotein lipase, endothelial lipase) but could not
detect changes in transcript levels. The lack of validation of targets
in triglyceride utilization in the mice suggests that CERT
heterozygotes may not be the ideal model for lipolytic mechanisms
and also reflects the complexities involved in lipid sensing in the
gut and coordination with other organs in the mammalian
systems.
Discussion
In this study, we have attempted to understand how dcerk1 flies
survive and adapt to increased ceramide level, which disrupts
several of the physiological metabolic pathways. Our results
collectively suggest that in the presence of increased ceramide, the
most important coping strategies for organismal survival are
geared towards energy production through metabolic remodeling
involving upregulation of genes that function in breakdown of
dietary nutrients, increased glycolysis and utilization of stored fat
in the gut. This is due to increased activation of PI3K/AKT/
FOXO pathway and subsequent activation of novel downstream
effectors (summarized in a model, Figure 7D). Failure of this
compensatory mechanism (due to aging or genetic reduction) leads
to TAG accumulation, increased starvation sensitivity and cardiac
abnormalities.
While dcerk1 flies are viable, genetic reduction of AKT results in
lethality showing survival of dcerk1 is dependent on increased
activation of AKT. AKT activation leads to increased glycolytic
flux in the mutants. Increase in lactate level in dcerk1 (in the
presence of sufficient oxygen) is reminiscent of aerobic glycolysis
observed in normal proliferating cells as well as in cancer cells. In
normal proliferating cells, increasing glycolytic intermediates has
been proposed to support macromolecular synthesis while a
similar phenomenon called Warburg effect is observed in cancer
cells where glycolysis is increased to provide energy to cells
defective in mitochondrial respiration [54,55]. AKT does not
activate its traditional targets of glycolysis such as hexokinase and
phosphofructokinase in dcerk1 but rather Pglym and downstream
glycolytic enzymes. Historically Pglym has not been viewed as a
rate-limiting step in glycolysis although studies have suggested its
importance in heart, phagocytic cells and cancer cells [56,57].
Thus, within the glycolytic pathway, control of metabolic flux can
be achieved by exerting control on different enzymes depending
on cellular conditions and Pglym could be an important node in
normal proliferating as well as in stressed cells. Addition of
ceramide analogs has been reported to inhibit AKT activation
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without affecting upstream signaling events [58,59]. Possible
mechanisms include activation of protein phosphatase 2A, which
could dephosphorylate AKT and interference with membrane
recruitment of AKT by atypical protein kinase C [59,60]. These
effects could in part be due to use of pharmacological amounts of
ceramide analogs, which likely do not mimic endogenous
ceramide. Nevertheless, these effects could be negated by
overexpression of constitutively active AKT [59]. How is AKT
Figure 6. Failure of adaptive mechanisms leads to cardiac dysfunction and reduction in adult life span of dcerk1. (A). Measurement of
Pglym enzyme activity in young (1 week) and aged (6 weeks) w1118 and dcerk1 flies shows a significant decrease in activity in older dcerk1. (B).
Comparison of transcript levels of CG8093 and CG6277 by QPCR in 1week and 6 week old flies, reveals decrease in their transcripts in aged dcerk1
flies. (C). Comparison of several cardiac performance indices in 1 and 3 week old esgGAL4 dcerk1 flies reveals progressive decline in heart function
with decreased heart rate, increased heart period and dilated heart chamber. n = 15, bar represents standard error of mean and statistical significance
was determined using Student’s t test; * denotes P,= 0.05-0.01, ** is P,= 0.01-0.001 is and *** denotes P,= 0.001-0.0001. (D). Knockdown of
CG6277 in 3 week old wild type flies also shows decreased heart rate, increased heart period, dilated heart chamber and arrhythmia. n = 10, bar
represents standard error of mean and statistical significance was determined using Student’s t test; * denotes P,= 0.05-0.01, ** is P,= 0.01-0.001 is
and *** denotes P,=0.001-0.0001. (E). dcerk1 have reduced adult life span compared to w1118 flies. The survivorship curve of dcerk1 and w1118
represents data from 600 flies in duplicate.
doi:10.1371/journal.pgen.1003556.g006
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activation achieved in dcerk1? While several mechanisms could
contribute to AKT activation, an idea we favor is that more PIP2 is
available for PI3K since utilization of PIP2 by PLC is severely
decreased due to its degradation in dcerk1 [10]. While we see an
increase in tGPH suggesting an increase in PIP3, we have not been
able to quantify PIP3 level by mass spectrometry. However, PIP2
level shows 60% increase in dcerk1 compared to control [10].
Studies in Drosophila have highlighted the role of Brummer lipase
(ATGL homolog) in fat storage and mobilization from the fat body
and in mice have shown ATGL mediated lipolysis is important for
PPARa-PGC1 complex activity and heart function [19,61].
Magro, a target of the nuclear receptor DHR96, hydrolyzes
dietary lipids in the gut as well as stored cholesterol esters
highlighting the importance of the Drosophila gut in maintaining
TAG and cholesterol homeostasis [62,63]. In mammalian systems,
understanding of lipid sensing by the intestine and its coordination
with other organs such as the liver, brain and the signaling
pathways in these organs that alter glucose and energy homeostasis
are just beginning to be explored [64]. Our results suggest
utilization of stored TAG from the gut is an important mechanism
in times of energy need such as starvation stress and CG8093 and
CG6277 are critical targets of AKT/FOXO in this process. In a
Drosophila larval model of type 2 diabetes that is accompanied by
high sugar and TAG levels, gene expression changes reveal that
CG8093 and CG6277 are both significantly downregulated (15
and 5 fold respectively) suggesting these lipases could have a role in
hypertriglyceridemia associated with diabetes [65]. Metabolic
control of lipolysis has been primarily studied at the level of
nutrient-sensing signal transduction cascades rather than tran-
scriptional regulation and hence not much is known about the
regulation of lipases by FOXO. In Drosophila, dFOXO has been
shown to directly regulate an acid lipase, dlip4 [66]. Recent studies
show a hormone dependent module consisting of salt induced
kinase SIK3, the histone deacetylase HDAC4, which regulate
FOXO activity in lipolysis [67]. In C.elegans, fat mobilization
through induction of a triglyceride lipase K04A8.5, a target of
DAF16 increases longevity [68]. In mammalian systems, FOXO
has been shown to regulate lipolysis by either directly controlling
expression of ATGL or through PPARc [69]. A forkhead factor,
FKHR has been shown to upregulate lipoprotein lipase expression
in the skeletal muscle [70]. While FOXO binding sites have been
identified in the promoter region of lipoprotein lipase, that it can
modulate its expression directly has yet to be demonstrated [71].
Further understanding of the role of FOXOs in different organs
will allow the exploration of the therapeutic value of targeting
FOXO in metabolic diseases.
Many recent studies show sphingolipids could be relevant to
changes in carbohydrate and fat levels. In Drosophila, overexpres-
sion of glucosylceramide synthase that catalyzes synthesis of
glucosylceramide increases TAG and carbohydrate levels while a
reduction causes decrease in fat storage [72]. Drosophila ceramide
synthase mutants also show reduction in fat storage [73]. In
mammalian systems, mice lacking sphingomyelin synthase and
ceramide kinase (both of which show increase ceramide levels) are
resistant to high fat diet induced obesity [74,75]. It would be
interesting to test if these animals show increased lipolytic
mechanisms based on our observations in Drosophila. Our results
with the dcerk mutant presented here as well as other mutants of
Figure 7. Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. (A). Total AKT and
phosphoAKT levels are monitored in liver extracts from wild type (+/+) and CERT heterozygous (+/2) mice. PhosphoAKT level is increased in CERT
heterozygotes while total AKT is not significantly changed. (B). Comparison of different FOXO in liver tissue of wild type (+/+) and CERT heterozygous
(+/2) mice shows significant decrease in their transcript levels. (C). Comparison of glycolytic genes in skeletal muscle from wild type (+/+) and CERT
heterozygous (+/2) mice shows greater than 5 fold increase in transcript levels of phosphoglycerate mutase and pyruvate kinase and 1.8 fold
increase in hexokinase. (D). A simple graphical model depicting metabolic reprogramming in dcerk1 due to increased AKT activation and decreased
FOXO to maintain energy balance. dcerk1 mutants show glucose utilization through increased glycolytic flux mediated by Pglym and downstream
enzymes. They also show increased utilization of triglycerides mediated by CG8093 and CG6277.
doi:10.1371/journal.pgen.1003556.g007
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Drosophila sphingolipid enzymes (our unpublished observations)
suggest that an increase in ceramide in one cellular compartment
eventually leads to an increase in ceramide in the mitochondria
suggesting that a central effect of ceramide accumulation in an
organism is impairment of mitochondrial function. This impact on
mitochondria is also being validated in recent mice knock out
studies such as the sphingomyelin synthase 2 and CERT mutants,
which show mitochondrial dysfunction [16,28].
The mechanisms outlined here could not only mediate
adaptation to ceramide, but could be important responses to
reduced energy availability. The ‘protective effects’ of the adaptive
mechanisms revealed here suggest that they have potential
therapeutic implications in ceramide mediated stress involving
decreased energy leading to high sugar and TAG levels, ultimately
resulting in cardiac dysfunction. Also, importantly, the identifica-
tion of novel downstream targets in the AKT/FOXO pathway
opens the possibility of new therapeutic targets in treatment of
cardiac dysfunction, hyperglycemia and hypertriglyceridemia.
Materials and Methods
Fly stocks and husbandry
Drosophila stocks were raised on standard corn meal agar and
maintained at 25uC. 2–7 day old flies were used in all experiments
unless otherwise indicated. Akt4226, actin-GAL4 driver, MHC-
GAL4 driver and tGPH flies were obtained from Bloomington
Stock Center (Indiana University). UAS-FOXO was a gift from
Marc Tatar (BrownUniversity, Providence), esg-Gal4 fromNorbert
Perrimon (Harvard Medical School, Boston) C564-GAL4 flies from
Neal Silverman (UMass, Worcester) and DTS flies were from Eric
Baerahcke (UMass, Worcester). UAS RNAi lines for CG8093,
CG6277 and Pglym were obtained from VDRC (Vienna). Akt4226
was recombined to dcerk1 to obtain dcerk1.akt/dcerk1 flies. UASRNAi
lines for CG8093, CG6277 and Pglym on the third chromosome
were recombined to dcerk1 to obtain dcerk1.UASCG8093RNAi,
dcerk1.UASCG6277RNAi and dcerk1.UASPglymRNAi lines. UAS-
FOXO, esg-GAL4, actin-GAL4, C564-GAL4 and MHC-GAL4
drivers on second chromosome were used.
Microarray analysis
dcerk1 and w1118 flies were collected, and RNAwas extracted using
TRIzol (Invitrogen) and purified on RNeasy columns (QIAGEN).
All samples were prepared in triplicate to facilitate subsequent
statistical analysis. Purified RNA was sent to Expression Analysis
(Durham, NC), where it was labeled and hybridized to Affymetrix
Drosophila 2.0 microarrays. The details of the analysis are
described in Supplemental Materials and Methods (Text S1).
Metabolic profiling
dcerk1 and w1118 (100 flies each, in triplicate) were collected and
frozen. The samples were prepared and analyzed by LC/MS, LC/
MS/MS and GC/MS platforms by Metabolon (Durham, NC).
ATP, TAG, trehalose, glycerol and free fatty acid
measurements
TAG measurement was carried out using the Serum triglyceride
determination kit (TR0100; Sigma, St. Louis, MO). Total body and
circulating trehalose were measured using a glucose reagent
(GAGO-20, Sigma) followed by porcine kidney trehalase (Sigma,
T8778). ATP measurements were carried out using an ATP assay
kit (Calbiochem). Glycerol and free fatty acid were determined using
coupled enzyme assay kits (Zenbio, NC). Detailed methodology is
provided in Supplemental Materials and Methods (Text S1).
Starvation assay
In each experiment, 10 batches of 20 flies for each genotype
were transferred to vials containing a small piece of sponge soaked
with water. Dead flies were counted at 6 h intervals.
Longevity assay
Newly eclosed adult w1118 and dcerk1 were collected over a 24
hr period and divided into batches of 20 flies per vial. Flies were
transferred to fresh food vials and scored for survival every 48 h.
Fly heartbeat analysis
Semi-intact fly heart preparations were used for heart param-
eter measurements according to published protocols [20]. High
speed 1 min movies were taken at a rate of .100 frames per
second using a Hamamatsu CCD camera on a Leica DM LFSA
microscope with a 106dipping immersion lens. The images were
processed using Simple PCI imaging software (Hamamatsu Inc.).
Cardiac parameters including heart rate, heart period, diastolic
and systolic intervals, diameters, fractional shortening and
arrhythmic index were generated using a MatLab-based image
analysis program.
Adult gut and larval fat body staining
For Oil red O staining, midguts from 2–7 days old adult flies
were dissected and fixed in 4% paraformaldehyde/PBS for
30 min at room temperature. The midguts were washed four
times in PBS and incubated for 20 to 30 min in 0.1% Oil Red
O stain (prepared fresh in isopropanol:water and passed
through a 0.45 mm syringe filter). Midguts were washed three
times with PBS, and mounted in 20% glycerol/PBS. The guts
were imaged immediately using Differential Interference
Contrast microscopy in a Nikon Eclipse E-600 microscope.
For visualization of tGPH, adult midgut or fat body from early
third instar larvae were dissected in PBS and visualized
immediately using Nikon Eclipse E-600 microscope and NIS-
Elements Imaging Software.
Quantitative RT-PCR
Total RNA was extracted using TRIzol reagent and cDNA was
synthesized using the SuperScript III first–Strand Synthesis kit
(invitrogen). Real time PCR was performed in the ABI PRISM
7000 sequence Detection System (Applied Biosystems) using
SYBR Green Supermix (Invitrogen). Reactions were normalized
to RP49 levels. Detailed methodology and primers used are
provided in Supplemental Materials and Methods (Text S1).
Luciferase assays
Constructs. A 2.4-kb fragment containing two FOXO core
motif sites WWAACA in the putative regulatory region of CG8093
(chr2R 10725084 – 10727488) was identified. This fragment was
cloned in pGL4-basic vector, which has a firefly luciferase reporter
gene (Promega). The fragment was amplified by PCR from genomic
DNA of flies using the following primers F59GGGGGCTAGCGA-
CAGCTACTTACATCCAAGCAATA39 and R59GGGGCTCG
AGCAACGAGCTCAAATTGGGTAAGA-39and cloned between
NheI and XhoI sites (pGLCG8093 2.4). The FOXO deficient
fragment was generated by using primers F59GGGGGCTAGCC
ACGAGAAATGTCAGGAAGTAATG39 and R59GGGGGC
TAGCCACGAGAAATGTCAGGAAGTAATG39 and cloned in
pGL4 vector between NheI and XhoI sites (pGLCG8093 1.3kbdel).
The empty pAc5.1 vector and constitutively active version of
dFOXO in pAc5.1 vector were gifts from Drs. Oscar Puig and
Jaakko Mattila.
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Cell culture and transfection. Drosophila Schneider (S2) cells
were grown in Schneider medium with 10% heat-inactivated fetal
bovine serum, penicillin, and streptomycin in 25uC in suspension. For
transfection, 16105 S2 cells were plated per well in a 96 -well plate in
triplicates. Cells were transfected using Effectene transfection reagent
(Qiagen) according to the manufacturer’s instructions. For transfec-
tions, 100 ng of expression vector (pAcFOXOA3 or pAc5.1) and
100 ng of reporter vector (pGLCG8093 2.4, pGLCG80931.3del)
along with renilla plasmid (20 ng) were used. After 30 h of transfection,
luciferase assays were performed using the dual-glow luciferase assay
system as per manufacturer’s protocol (Promega). Each experiment
was repeated three times.
Immunoblotting
Flies were crushed in SDS-sample buffer; the extracts were
centrifuged and separated by SDS-PAGE followed by Western
blotting using antibodies to AKT (1:1000, Cell Signaling) and
phospho Drosophila AKT Ser505 (1:1000, Cell Signaling).
Measurement of activity of glycolytic enzymes
Soluble extracts were prepared from approximately 1000 flies
per batch using different buffers for different enzymes and
spectrophotometric assays were carried out as detailed in
Supplemental Materials and Methods (Text S1).
Assays for mitochondrial oxidative phosphorylation
complexes
Mitochondria were isolated from approximately 1000 flies per
batch. The activity of each of the five complexes was determined
spectrophometrically as detailed in Supplemental Materials and
Methods (Text S1).
Supporting Information
Figure S1 Ceramide levels increase while ceramide 1-phosphate
levels are not significantly affected in dcerk1 mutant fly extracts
compared to w1118. (A). d14 long chain base ceramide with
different fatty acids, C20:0, C22:0, C24;1 and C24:0 are estimated
by mass spectrometry in sphingolipid enriched fractions prepared
from w1118 and dcerk1 flies. The amount of ceramide is calculated
based on total carbon content and then normalized to w1118. All
ceramides show significant increase (P,=0.001-0.0001) in
mutant compared to w1118. n = 3, error bars represent standard
deviation. (B). d14 long chain base ceramide 1-phosphate (C1P)
with fatty acids C20:0, C22:0 and C24:0 are estimated by mass
spectrometry. A 20% decrease in C24:0 C1P is observed in mutant
relative to w1118. n = 3, error bars represent standard deviation.
(TIF)
Figure S2 Western blot of total AKT and phospho AKT level in
akt4226/+ heterozygotes. (A). Western blot of total AKT and
phospho AKT in w1118, dcerk1 and akt4226/+. (B). Quantification of
the blots by densitometric scanning shows a 50% decrease in total
AKT and 30% reduction in pAKT in the heterozygote. n = 3.
(TIF)
Figure S3 Ubiquitous RNAi knockdown of Pglym in w1118 and
dcerk1. Combining actin GAL4 driver with UASPglymRNAi
transgene results in significant reduction in Pglym transcript level
in w1118 and dcerk1. n = 3, error bars represent standard deviation.
(TIF)
Figure S4 CG6277 and CG8093 show high expression in the
adult midgut. QPCR analysis is carried out using total RNA
extracted from adult head and dissected adult midgut from w1118.
CG6277 shows approximately 20-fold increase in transcript level
in the midgut compared to head while CG8093 shows a 5 fold
increase suggesting these genes are highly expressed in the adult
midgut. n = 3, error bars represent standard deviation.
(TIF)
Figure S5 Gut epithelial integrity and epithelial renewal is not
compromised in dcerk1 mutants. A. w1118 and dcerk1 gut are stained
with Armadillo (b-Catenin homolog), an important component of
adherens junctions. The nuclei are stained with DAPI. Armadillo
staining is not significantly different between w1118 and dcerk1
suggesting epithelial integrity is not compromised in the mutant.
Scale bar represents 25 mm. B. This panel shows w1118 and dcerk1
midguts expressing esg-GAL4 GFP, which marks enteroblasts and
intestinal stem cells involved in epithelium renewal. GFP staining is
not significantly different between control and mutant guts. The
guts are also stained with DAPI. Scale bar represents 50 mm. C.
Survival of dcerk1 is not significantly different from w1118 upon
ingestion of Pseudomonas entomophila. Increased epithelial renewal is
required in the gut to make up for damage caused by oral pathogens
and flies with low epithelial renewal succumb to bacterial infection
earlier than control flies. However, dcerk1 flies died at a similar rate
as controls when fed Pseudomonas entomophila suggesting epithelial
renewal in response to gut damage in dcerk1 is not compromised.
(TIF)
Figure S6 Gut specific knockdown of CG8093 and CG6277 in
w1118 and dcerk1. Combining expression of esg-GAL4 driver and
UASCG8093RNAi transgene effectively reduces CG8093 tran-
script level in w1118 and dcerk1 flies. Similarly, combining
expression of esg-GAL4 driver and UASCG6277RNAi transgene
effectively reduces CG6277 transcript level in w1118 and dcerk1 flies.
n = 3, error bars represent standard deviation.
(TIF)
Figure S7 Knockdown of CG8093 and CG6277 in w1118 results
in increased Oil Red O puncta in the midgut. Dissected adult
midguts stained with Oil Red O show significantly increased
staining in RNAi knockdown in w1118 compared to RNAi controls.
Oil Red O puncta are significantly more in the right panels and
the puncta also appear bigger in CG8093 knockdown. 15–20 guts
are examined for each genotype in one experiment, n = 3.
(TIF)
Figure S8 Quantification of cardiac function parameters in
RNAi knockdown of CG8093 in wild type and dcerk1. Knockdown
of CG8093 does not show significant changes in most of the
parameters tested in both backgrounds. However, heart period is
increased due to expansion of diastolic interval in dcerk1 when
CG8093 is knocked down. n = 11–13 for each group. Bar
represents standard error of mean.
(TIF)
Figure S9 Assessment of starvation sensitivity and cardiac
function parameters in RNAi knockdown of Pglym in wild type
and dcerk1. Ubiquitous knockdown of Pglym results in significant
increase in starvation sensitivity in both backgrounds. Knockdown
of Pglym decreases diastolic and systolic diameters in both
backgrounds. n = 11–13. Bar represents standard error of mean.
(TIF)
Table S1 List of increased and decreased genes from microarray
analysis. List of genes whose expression either increase by 2 fold or more
or decrease by 0.5 fold or less in dcerk1 compared to w1118 flies is shown.
The columns represent Affymetrix ID, CG number, log fold change, P
value, normalized log 2 transformed intensity and present call.
(PDF)
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Table S2 List of candidate genes from microarray analysis that
contain FOXO binding sites. The table shows genes from the
microarray analysis for which potential FOXO binding sites were
identified. The columns show FBgn ID with chromosome location,
strand, gene start and end positions, CG numbers, peak start and
end positions, distance to peak, shortest distance to peak and
whether it is overlapping or nearest.
(PDF)
Table S3 Fold change (dcerk1/w1118) of metabolites and their
classification into different pathways. The table shows relative
changes in different metabolites between control and mutant flies.
The metabolites have been classified into functional pathways. A p
value of 0.05 or less and q value (false discovery rate) of 0.1 or less
is considered statistically significant.
(PDF)
Text S1 Methodology detailed in Supplemental Materials and
Methods. Additional details are provided for microarray analysis,
metabolic assays including measurements of TAG, trehalose,
ATP, free fatty acid and glycerol, QPCR analysis, immunofluo-
rescence microscopy, activity measurements for glycolytic en-
zymes, assays for mitochondrial oxidative phosphorylation com-
plexes and feeding of Pseudomonas entomophila.
(DOCX)
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